Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says - 2Planet-eating stars hint at Earth's ultimate fate
- 3Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it
- 4The most effective method to Pick the Right Material Organization: Your Definitive Aide
- 5Instructions to Amplify Certifiable Experience While Chasing after an Internet Advertising Degree
- Mom finds out she has cancer after noticing something was off while breastfeeding
- British-Egyptian dissident apologises for tweets as Tories push for UK deportation
- The 2026 'Super Bowl of Astronomy' starts today — here's what's happening
- Vote in favor of your Favored Kind of Scarf
- 7 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
- Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips
- The most effective method to Pick the Right Teeth Substitution Choice for You
- Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
- 6 Nations for Setting up camp
